VIVAT NV announces Tender Offer for any and all of its EUR 650,000,000 Fixed Rate Unsubordinated Notes due 2024
The Purchase Price for the Notes will be determined by reference to a spread of 160 bps over the interpolated mid-swap rate as detailed in the Tender Offer Memorandum dated 2 April 2020. Copies of the Tender Offer Memorandum are (subject to offer restrictions) available from the Tender Agent as set out below. Capitalised terms used and not otherwise defined in this announcement have the meanings given to them in the Tender Offer Memorandum.
Today, Athora announced that it has completed its acquisition of VIVAT by acquiring 100% of the shares from Anbang. Subsequently, Athora has sold 100% of the shares of VIVAT Non-life to NN Group.
VIVAT today published its 2019 Annual Report, an integrated review of the company’s performance, consisting of the Board Report and the Financial Statements. In addition, the reports of SRLEV NV and VIVAT Schadeverzekeringen NV were published.
Today, VIVAT has been informed that Athora received a DNO from De Nederlandsche Bank (DNB) for the acquisition of VIVAT. NN has also received a DNO from DNB in relation to its follow-on acquisition of VIVAT Non-Life. The closing of the transaction is expected in early April 2020.
Today, VIVAT published its Annual Results 2019. VIVAT is well prepared for the future, with a solid financial performance and a resilient Solvency II capital.
VIVAT NV (VIVAT) announces today that Tom Kliphuis has been appointed as Chief Executive Officer (CEO) of VIVAT, effective April 1 2020. Kliphuis, currently Chairman of the Executive Board of Coöperatie VGZ, succeeds Ron van Oijen who has resigned as CEO of VIVAT as of January 31, 2020.
VIVAT NV (VIVAT) announces today that, by mutual agreement, Chief Executive Officer Ron van Oijen resigns from his position effective January 31, 2020.
Net Underlying Result improved to EUR 161 million (1H18: EUR 115 million), driven by higher investment income and improved claims ratio of P&C. Combined ratio improved to 96.0% reflecting an improved claims ratio (1H18: 100.9%)